# Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation

> **NCT06570096** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Premixed
- Sequential
- Lidocaine
- Bupivacaine
- Supraclavicular Brachial Plexus Block
- Arteriovenous Fistula

## Interventions

- **DRUG:** Lidocaine 2% then bupivacaine 0.5%
- **DRUG:** Lidocaine 2% and bupivacaine 0.5%

## Key facts

- **NCT ID:** NCT06570096
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-24
- **Primary completion:** 2025-03-16
- **Final completion:** 2025-03-16
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570096, "Premixed vs Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06570096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*